National Health Act (Pharmaceutical Benefits – Early Supply) Amendment March 2010 - specification under subsection 84AAA(2) (No. PB 11 of 2010)

Link to law: https://www.comlaw.gov.au/Details/F2010L00535

 
COMMONWEALTH OF AUSTRALIA
Instrument number PB 11 of 2010
National Health (Pharmaceutical Benefits – Early Supply) Amendment March 2010 - Specification Under Subsection 84AAA(2)
 
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
 
I, Felicity McNeill, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
 
Dated                    22      February 2010
 
 
FELICITY MCNEILL
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
 
 
 
Amendment determination — Pharmaceutical Benefits - Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment March 2010 - specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as “No. PB 11 of 2010”.
 
2          Commencement
 
This Instrument commences on 1 March 2010.
 
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.
 
Schedule 1        Amendments
[1]                                  Schedule 1, after item dealing with Candesartan with hydrochlorothiazide, Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg
insert in the columns in the order indicated:
 
 
Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg
Oral
30
5
 

Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg
Oral
30
5
 

 
[2]                                  Schedule 1, after item dealing with Gemfibrozil
insert in the columns in the order indicated:
 
Gliclazide
Tablet 60 mg (modified release)
Oral
60
5
 
 
[3]                                  Schedule 1, after item dealing with Moxonidine
insert in the columns in the order indicated:
 
Nebivolol
Tablet 1.25 mg (as hydrochloride), 28
Oral
1
5
 

Tablet 1.25 mg (as hydrochloride)
Oral
56
5
 

Tablet 5 mg (as hydrochloride)
Oral
28
5
 

Tablet 10 mg (as hydrochloride)
Oral
28
5
 

 
Read Entire Law on www.comlaw.gov.au